✦ LIBER ✦

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE

✍ Scribed by Cummings, Jeffrey; Cho, William; Ward, Michael; Friesenhahn, Michel; Brunstein, Flavia; Honigberg, Lee; Clayton, David; Mortensen, Deborah; Ho, Carole; Paul, Robert

Book ID: 126234978
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 51 KB
Volume: 10
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2014.04.450

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A long-term, double-blind, placebo-contr

A long-term, double-blind, placebo-controlled efficacy and safety study of nicergoline in patients with mild to moderate Alzheimer's disease

✍ L. Amaducci; K. Maurer; B. Winblad; R. Dom; R. Bullock; L. Bonura; A. Battaglia; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 291 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre

A Randomized, Double-blind, Placebo-Cont

A Randomized, Double-blind, Placebo-Controlled Study of Latrepirdine in Patients With Mild to Moderate Huntington Disease

📂 Article 📅 2013 🏛 American Medical Association 🌐 English ⚖ 231 KB

A 24-week, randomized, double-blind, pla

A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease

✍ Nakamura, Yu; Imai, Yukimichi; Shigeta, Masahiro; Graf, Ana; Shirahase, Toru; Ki 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

929a A Phase 2, Randomized, Double-blind

929a A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of RM-131 in Patients with Diabetic Gastroparesis

✍ Lembo, Anthony; Camilleri, Michael; McCallum, Richard W.; Sastre, Ramon F.; Bret 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Mo2083 A Randomized, Double-Blind, Place

Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease

✍ Stephan R. Targan; Brian G. Feagan; Severine Vermeire; Remo Panaccione; Gil Y. M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB